Sheldon H. Preskorn, M.D.

Professional Background

Sheldon Preskorn, M.D. is a medical doctor specializing in psychiatry. Dr. Preskorn currently teaches PGY3 resident psychiatrists in assessment and management of outpatients with psychiatric illness.

Dr. Preskorn has authored over 500 professional publications and have been cited over 15,000 in the medical literature.

• MD, Univ. of Kansas-Medical Ctr.
• Residency, Washington University School of Medicine, St. Louis, MO

• Kansas Medical License, Board of Healing Arts

---

• Preskorn Sheldon H., Zeller S, Citrome Leslie, Goldberg Joseph, Risinger Robert, Fava Mauricio, Kakar Rishi, DeVivo Michael, Yocca Frank. 2021. BXCL501 Achieves Rapid Control of Agitation in Patients with Bipolar Disorder.
• Preskorn Sheldon H. 2021. QTc, the Multitude of Ways It Is Calculated and Implications for Clinical Practice: A Case Example. Journal of Psychiatric Practice, 27 ( (1)), 43-47
• Preskorn Sheldon H. 2021. Charting and Handling Genetic Test Results: How They Differ From Most Laboratory Results. Journal of Psychiatric Practice
• Preskorn Sheldon H. 2021. Consistency of the Antidepressant Effect of Intranasal Esketamine in Phase 3 Clinical Trials. Journal of Psychiatric Practice
• Citrome Leslie, Preskorn Sheldon H, Lauriello John, Krystal John, Kakar Rishi, Finman Jon, DeViVo Michael, Yocca Frank, Risinger Robert. 2021. A Rapidly Effective Treatment for Agitation in Schizophrenia: BXCL501, an Orally Dissolving Film of Dexmedetomidine.
• Preskorn Sheldon. 2020. COVID-19: Why Has the Mortality Rate Declined?. Journal of Psychiatric Practice, 26 ((5) ), 394-399
• Preskorn Sheldon H, Quadri Syeda. 2020. Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions? . 2020 Nov; . Journal of Psychiatric Practice, 26 ((6)), 485–492
• Preskorn Sheldon H. 2020. Two Clinically Important but Underutilized and Misunderstood Tools: Formulas to Estimate Creatinine Clearance and Therapeutic Drug Monitoring. Journal of Psychiatric Practice, 26 ((4)), 305-308
• Preskorn Sheldon H. 2020. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy. Journal of Psychiatric Practice, 26 ((3)), 219-227
• Preskorn Sheldon H. 2020. Mental Health Care Providers Dealing With Coronavirus Disease 2019 (COVID-19): What Is the Definition of a Case, How Is That Changing, and What Kinds of Tests Are Available?. Journal of Psychiatric Practice, 26 ((3)), 215-218